Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.56 |
| ▸ | PPARG | P37231 | 7/20 | 0.56 |
| ▸ | PPARD | Q03181 | 7/20 | 0.56 |
| ▸ | PPARA | Q07869 | 7/20 | 0.56 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TLR2 | O60603 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | FABP4 | P15090 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.56 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | PDE4A | P27815 | 1/20 | 0.56 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8643046 | 1.00 | GPR84 (0.56) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL10420858 | 1.00 | GPR84 (0.56) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL6870561 | 1.00 | GPR84 (0.56) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL14566020 | 1.00 | GPR84 (0.56) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL31273343 | 1.00 | GPR84 (0.56) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL10511281 | 0.92 | GPR84 (0.52) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL10787440 | 0.92 | AKR1B1 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL6708723 | 0.92 | CA12 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL10727061 | 0.92 | CA12 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL10727436 | 0.92 | CA12 (0.50) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600743-B2 | Method for producing oligonucleic acid compound | NIPPON SHINYAKU CO., LTD. (JP) | 2026-04-14 | — | — | US | disclosed |
| US-12600744-B2 | Method for producing oligonucleic acid compound | NIPPON SHINYAKU CO., LTD. (JP) | 2026-04-14 | — | — | US | disclosed |
| US-20240254158-A1 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | NIPPON SHINYAKU CO., LTD. (JP) | 2024-08-01 | — | — | US | disclosed |
| CN-112384520-B | Method for producing oligonucleotide compound | 日本新药株式会社 | 2024-06-11 | — | — | CN | disclosed |
| EP-4332111-A1 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | Nippon Shinyaku Co., Ltd. (JP) | 2024-03-06 | — | — | EP | disclosed |
| CN-117279926-A | Method for producing oligonucleotide compound | 日本新药株式会社 | 2023-12-22 | — | — | CN | disclosed |
| US-11560401-B2 | Method for preparing oligonucleic acid compound | NIPPON SHINYAKU CO., LTD. (JP) | 2023-01-24 | — | — | US | disclosed |
| US-20230014840-A1 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | NIPPON SHINYAKU CO., LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| US-20230018780-A1 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | NIPPON SHINYAKU CO., LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| WO-2022230954-A1 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | 日本新薬株式会社 | 2022-11-03 | — | — | WO | disclosed |
| US-6107286-A | COMPLEXING WITH NUCLEIC ACIDS | RHONE-POULENC RORER S.A. (FR) | 2000-08-22 | — | — | US | disclosed |
| WO-2000030688-A2 | AMPHIPATIC POLYCARBOXYLIC CHELATES AND COMPLEXES WITH PARAMAGNETIC METALS AS MRI CONTRAST AGENTS | BRACCO INTERNATIONAL B.V. (NL) | 2000-06-02 | — | — | WO | disclosed |
| EP-0796240-A1 | LIPOPOLYAMINES AS TRANSFECTION AGENTS AND PHARMACEUTICAL USES THEREOF | Aventis Pharma S.A. (FR) | 1997-09-24 | — | — | EP | disclosed |
| WO-1996017823-A1 | LIPOPOLYAMINES AS TRANSFECTION AGENTS AND PHARMACEUTICAL USES THEREOF | RHONE-POULENC RORER S.A. (FR) | 1996-06-13 | — | — | WO | disclosed |
| US-4921942-A | Organometallic compounds | STEPAN COMPANY (US) | 1990-05-01 | — | — | US | disclosed |
| US-4724174-A | AMIDO CARBOXYL SOAPS; FILM-FORMING; SUBSTANTIVITY | STEPAN COMPANY (US) | 1988-02-09 | — | — | US | disclosed |
| US-4675422-A | ALUMINUM COATINGS | STEPAN COMPANY (US) | 1987-06-23 | — | — | US | disclosed |
| US-4258061-A | TO COMBAT VIRAL DISEASE | PFIZER INC. (US) | 1981-03-24 | — | — | US | disclosed |
| US-4087552-A | ANTIVIRAL | PFIZER INC. (US) | 1978-05-02 | — | — | US | disclosed |
| US-4034040-A | Xylene-diamines as antiviral agents | PFIZER INC. (US) | 1977-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600743-B2 | Method for producing oligonucleic acid compound | SUB1, CTDSP1, POLR1A | GPR84 4195/4885PPARG 3600/4885PPARD 4045/4885 |
| US-20230018780-A1 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | POLRMT, POLR2H, POLM | GPR84 4802/4885PPARG 4298/4885PPARD 3519/4885 |
| US-11560401-B2 | Method for preparing oligonucleic acid compound | POLRMT, POLI, POLR2H | GPR84 4769/4885PPARG 3184/4885PPARD 3404/4885 |
| US-20240254158-A1 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | POLRMT, CYC1, MRM1 | GPR84 4131/4885PPARG 4279/4885PPARD 4404/4885 |
| US-20230014840-A1 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | DNASE1, XRN2, FBL | GPR84 4005/4885PPARG 4443/4885PPARD 4786/4885 |
| US-12600744-B2 | Method for producing oligonucleic acid compound | NSUN2, SUB1, RPA1 | GPR84 3292/4885PPARG 3266/4885PPARD 4536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.